JP2023529025A5 - - Google Patents
Info
- Publication number
- JP2023529025A5 JP2023529025A5 JP2023516644A JP2023516644A JP2023529025A5 JP 2023529025 A5 JP2023529025 A5 JP 2023529025A5 JP 2023516644 A JP2023516644 A JP 2023516644A JP 2023516644 A JP2023516644 A JP 2023516644A JP 2023529025 A5 JP2023529025 A5 JP 2023529025A5
- Authority
- JP
- Japan
- Prior art keywords
- cov
- sars
- pharmaceutical composition
- composition according
- hcov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20177451 | 2020-05-29 | ||
| EP20177451.0 | 2020-05-29 | ||
| EP20184767.0 | 2020-07-08 | ||
| EP20184767.0A EP3936132A1 (en) | 2020-07-08 | 2020-07-08 | Azelastine as antiviral treatment |
| EP20195740 | 2020-09-11 | ||
| EP20195740.4 | 2020-09-11 | ||
| EP21171333 | 2021-04-29 | ||
| EP21171333.4 | 2021-04-29 | ||
| PCT/EP2021/064338 WO2021239943A1 (en) | 2020-05-29 | 2021-05-28 | Azelastine as antiviral treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529025A JP2023529025A (ja) | 2023-07-06 |
| JP2023529025A5 true JP2023529025A5 (https=) | 2024-06-04 |
Family
ID=76059910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516644A Pending JP2023529025A (ja) | 2020-05-29 | 2021-05-28 | 抗ウイルス処置としてのアゼラスチン |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20230201216A1 (https=) |
| EP (2) | EP3934653B1 (https=) |
| JP (1) | JP2023529025A (https=) |
| KR (1) | KR20230021009A (https=) |
| CN (1) | CN116406273A (https=) |
| AU (1) | AU2021279280A1 (https=) |
| BR (1) | BR112022023897A2 (https=) |
| CA (1) | CA3184167A1 (https=) |
| DK (1) | DK3934653T3 (https=) |
| ES (1) | ES2937145T3 (https=) |
| FI (1) | FI3934653T3 (https=) |
| HU (1) | HUE060929T2 (https=) |
| IL (1) | IL298543A (https=) |
| JO (1) | JOP20220319B1 (https=) |
| LT (1) | LT3934653T (https=) |
| MX (1) | MX2022015074A (https=) |
| PL (1) | PL3934653T3 (https=) |
| RS (1) | RS63940B1 (https=) |
| SI (1) | SI3934653T1 (https=) |
| SM (1) | SMT202300036T1 (https=) |
| WO (1) | WO2021239943A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11806359B2 (en) | 2020-03-31 | 2023-11-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating Coronavirus infection |
| ES2937145T3 (es) * | 2020-05-29 | 2023-03-24 | CEBINA GmbH | Azelastina como tratamiento antiviral |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3877904D1 (de) * | 1987-11-13 | 1993-03-11 | Asta Pharma Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge. |
| DE3836579A1 (de) * | 1987-11-13 | 1989-05-24 | Asta Pharma Ag | Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge |
| US20100311656A1 (en) * | 2003-04-23 | 2010-12-09 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of respiratory viral infections with alpha thymosin peptides |
| US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| JP2008285474A (ja) | 2007-04-17 | 2008-11-27 | Daiichi Sankyo Healthcare Co Ltd | 抗アデノウイルス剤を含有する医薬組成物 |
| US8642069B2 (en) * | 2008-08-27 | 2014-02-04 | Alexander D. Goldin | Composition and method for treating colds |
| WO2021207213A2 (en) * | 2020-04-07 | 2021-10-14 | University Of Florida Research Foundation, Incorporated | Methods to prevent sars-cov-2 infection and treat covid-19 |
| US20230142221A1 (en) * | 2020-04-10 | 2023-05-11 | Kamal Khan Mubarak | Compositions and methods for modulating ace2 receptor |
| CN113521289A (zh) * | 2020-04-16 | 2021-10-22 | 中国科学院上海药物研究所 | 15种药物有效成分在抗病毒感染中的应用 |
| ES2937145T3 (es) * | 2020-05-29 | 2023-03-24 | CEBINA GmbH | Azelastina como tratamiento antiviral |
-
2021
- 2021-05-28 ES ES21727186T patent/ES2937145T3/es active Active
- 2021-05-28 CA CA3184167A patent/CA3184167A1/en active Pending
- 2021-05-28 WO PCT/EP2021/064338 patent/WO2021239943A1/en not_active Ceased
- 2021-05-28 HU HUE21727186A patent/HUE060929T2/hu unknown
- 2021-05-28 US US17/928,422 patent/US20230201216A1/en active Pending
- 2021-05-28 AU AU2021279280A patent/AU2021279280A1/en active Pending
- 2021-05-28 PL PL21727186.5T patent/PL3934653T3/pl unknown
- 2021-05-28 KR KR1020227045014A patent/KR20230021009A/ko active Pending
- 2021-05-28 JP JP2023516644A patent/JP2023529025A/ja active Pending
- 2021-05-28 LT LTEPPCT/EP2021/064338T patent/LT3934653T/lt unknown
- 2021-05-28 SI SI202130029T patent/SI3934653T1/sl unknown
- 2021-05-28 DK DK21727186.5T patent/DK3934653T3/da active
- 2021-05-28 FI FIEP21727186.5T patent/FI3934653T3/fi active
- 2021-05-28 IL IL298543A patent/IL298543A/en unknown
- 2021-05-28 MX MX2022015074A patent/MX2022015074A/es unknown
- 2021-05-28 CN CN202180059038.4A patent/CN116406273A/zh active Pending
- 2021-05-28 US US17/333,857 patent/US11273163B2/en active Active
- 2021-05-28 EP EP21727186.5A patent/EP3934653B1/en active Active
- 2021-05-28 RS RS20230083A patent/RS63940B1/sr unknown
- 2021-05-28 SM SM20230036T patent/SMT202300036T1/it unknown
- 2021-05-28 EP EP22206040.2A patent/EP4190333A1/en active Pending
- 2021-05-28 BR BR112022023897A patent/BR112022023897A2/pt unknown
- 2021-12-27 US US17/562,973 patent/US11433080B2/en active Active
-
2022
- 2022-11-21 JO JOJO/P/2022/0319A patent/JOP20220319B1/ar active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3057264T3 (en) | 5-amino-2,3-dihydro-1,4-phthalazinedione for use in the treatment of coronaviral infections | |
| CN102448438A (zh) | 抗流行性感冒调配物及方法 | |
| JP5970465B2 (ja) | ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物 | |
| JP2023529025A5 (https=) | ||
| CA2991156A1 (en) | Compositions and methods for the treatment of viral infection | |
| WO2020037095A1 (en) | Egcg-palmitate compositions and methods of use thereof | |
| KR20100021451A (ko) | 옥시부티닌 투여를 위한 방법 및 조성물 | |
| IL298543A (en) | Azalestine as an antiviral treatment | |
| JP2019516797A5 (https=) | ||
| CN104382841A (zh) | 鱼金注射剂用于制备直肠给药制剂及雾化吸入制剂的用途 | |
| US20230225988A1 (en) | Antiviral use of calixarenes | |
| JP7369523B2 (ja) | 中等度～重度のインフルエンザの処置 | |
| US20230346793A1 (en) | Compositions and Methods for Treating SARS-CoV-2 | |
| CN115867288A (zh) | 用于治疗呼吸系统病症的组合物 | |
| WO2022063320A1 (zh) | 一种抑制呼吸道病毒的组合物及呼吸道病毒防治方法 | |
| EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| CN111228247B (zh) | 一种用于治疗包虫病的含苯亚甲基丙酮药物及其制备方法 | |
| EA048350B1 (ru) | Применение даларгина для профилактики орви и предотвращения развития осложнений при заболеваниях орви | |
| CN115969788A (zh) | 一种喷雾剂式的阻断呼吸道病毒传播传染的卫生防疫品（准药物）和方法 | |
| US20230310467A1 (en) | PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19 | |
| WO2025067689A1 (en) | 5-amino-2,3-dihydro-1,4-phthalazinedione for the treatment of infections with an rna virus | |
| WO2022145407A1 (ja) | Ｄｐ１アンタゴニストおよびノイラミニダーゼ阻害剤からなるウイルス性気道感染症治療用医薬 | |
| WO2022216172A1 (ru) | Водная апротинин-содержащая противовирусная фармацевтическая композиция | |
| US20220096407A1 (en) | Composition for inhibiting respiratory viruses and respiratory virus prevention and treatment method | |
| KR20060123329A (ko) | 월경 곤란증의 예방 및/또는 치료제 |